N/A N=24 Response to Supplement and Placebo in GERD
Gastroesophageal Reflux Disease (GERD) · Heartburn · Dyspepsia
Primary: Safety - Number of Participants Experiencing a Serious Adverse Event — 0; 0; 0; 0 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=16 Single Low-Dose of Supplement Amino Acid
Growth Hormone · Amino Acid
Primary: Change From Baseline of Growth Hormone — 1.15; -0.48 nanograms/ml — p=0.01
N/A N=10 Effect of a Dietary Supplement on Quality of Life
Quality of Life
Primary: Chubon Lifestyle Score — 103.9; 100.9; 100.4; 102.9 score on a scale
N/A N=30 Impact of Nutritional Supplementation on Aerobic Performance and Fatigue
Performance · Fatigue
Primary: Perceived Exertion — 6.7; 7.4 units on a scale
N/A N=29 Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication
ADHD
Primary: Weight Change — 0.37; -0.04 kilograms
N/A N=141 Impact of Protein and Alkali Supplementation on Skeletal Muscle in Older Adults
Age-Related Sarcopenia · Muscle Loss
Primary: Double Leg Press Peak Power at 70% — 260.3; 255.6; 251.1; 264.8 Watts
N/A N=62 Dietary Supplement With and Without a Probiotic
Healthy Adult Subjects
Primary: Evaluation of the Levels of B.Infantis in Stool by Quantitative PCR — 3.33; 3.33; 3.33; 3.33 copies/ng DNA — p=<0.0001
N/A N=60 A Study to Evaluate the Effects of a Dietary Supplement on Children's Health and Development Outcomes.
Height · Cognitive Function · Weight Gain
Primary: Change Mean Percentile Score in Double Trouble — 168.55; 129.46 percent change from baseline — p=0.488445
N/A N=92 Dietary Supplement With and Without a Probiotic and/or Antibiotic
Healthy Adults
Primary: Evaluation of the Changes in Microbiome Species Abundance and Diversity From Baseline Until End of Study (Day 35) — 27.00; 31.25; 27.00; 27.00 copies/ng DNA — p=<0.0001
Phase 3 N=5,449 Complementary Food Supplements for Reducing Childhood Undernutrition
Stunting · Wasting
Primary: Stunting in Children at 18 mo — 559; 542; 341; 300 Participants
Phase 2 N=208 The Effect of Protein Supplementation on Bone Health in Healthy Older Men and Women
Bone Resorption · Osteoporosis
Primary: Change in Anterior-posterior Spine Bone Mass Density Measured by Dual Energy X-ray Absorptiometry (DXA) Compared to Baseline — 0.51; 0.51 percentage change
N/A N=90 Dietary Supplements for the Treatment of Angelman Syndrome
Angelman Syndrome · Nervous System Diseases
Primary: Average Change in Functioning in Specific Areas of Development, Including Speech and Communications Skills, Cognitive Abilities and Daily Living Skills — 5.7; 4.7; 5.8…
N/A N=13 Evaluation of the Ketogenic Potential of Different Diet Supplements
Healthy Adults
Primary: Concentration of Total Plasma Ketones — -18.2; 23; 12.2; 68.5 µmol/L
N/A N=28 Effects of Shroom Tech Sport Supplementation and Concurrent Training
Body Composition · Performance Measures · Hormone Profiles
Primary: Change in Body Fat as Measured by Bod Pod — 15.5; 16.2; 14.8; 15.3 Percent Body Fat
Phase 3 N=500 Supplemental Enteral Protein in Critical Illness
Nutrition Disorder · Trauma · Critical Illness
Primary: Serum Concentrations of Transthyretin at 3 Weeks After Injury. — 18.1; 18.9 mg/dl
Phase 2 N=16 Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder
Autism Spectrum Disorder
Primary: Change in Mitochondrial Activity in Study Patients: Citrate Synthase — 40.56; 29.09; 27.41; 37.78 nmoles/min/mg protein
N/A N=56 Vitamin D Supplementation in Healthy Adolescents
Vitamin D Supplementation
Primary: Baseline 25 Hydroxy Vitamin D (25OHD) Levels — 28.1; 29 ng/ml
Phase 4 N=300 Nutrition, Physical Performance & Fitness in Indian School Children
Physical Fitness · Nutritional Status
Primary: Change From Baseline in Maximal Aerobic Capacity (VO2max)- 12 Inch Step Test After 4 Months — 36.8; 37.9; 37.0; 38.9 mL/kg/min. — p=0.004
N/A N=11 A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants
Healthy, no Evidence of Disease
Primary: The Magnitude of Change in Blood Lymphocyte NF-kB Level — -40.51 Optical Density unit
N/A N=50 MINGO Supplemental Trial in X-linked Dystonia-Parkinsonism Patients
X-Linked Dystonia Parkinsonism
Primary: The Body Mass Index (BMI in kg/m^2) Using a Bathroom Weighing Scale. — 18.86; 18.17; 19.00; 18.31 Kg/m^2 — p=0.084
N/A N=8 Whole Body Protein Metabolism of a Whey/EAA Supplement Using Continuous Oral Stable Isotopes
Healthy
Primary: Whole-body Protein Net Balance — 6.2; 11.8 grams
N/A N=114 To Investigate the Impact of a Nutritional Supplement on Bone Turnover Markers in Indian Healthy Premenopausal Women (25- 45 Years) After 6 Months of Intervention
Growth and Development
Primary: Change From Baseline in Serum Cross Linking C-telopeptide of Type 1 Collagen (s-CTX-1) at 6 Months — 0.4440; 0.4410; 0.2828; 0.3245 Micrograms per litres (mcg/L)…
N/A N=61 Muscle Growth Following a Resistance Training Program in Men and Women Consuming Protein Supplements
Skeletal Muscle Growth
Primary: Lean Body Mass Change — 1.5; 1.3 kilogram — p=<0.05
N/A N=36 Vitamin C Supplementation Intervention
Heart Failure
Primary: Serum Vitamin C Level at Baseline — 13372; 16079; 13111 ng/mL
Phase 3 N=39 Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Change in Short Physical Performance Battery (SPPB) Score — 0.6; 0.9 units on a scale — p=0.55
Phase 3 N=4,203 Age-Related Eye Disease Study 2 (AREDS2)
Age-related Macular Degeneration · Cataract
Primary: Development of Advanced AMD in People at Moderate to High Risk for Progression. — 493; 468; 507; 472 Eyes — p=<0.013
N/A N=132 Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Prostate Adenocarcinoma
Primary: PSA Response — 0.55; 0.31 ng/mL — p=0.431
N/A N=20 Effect of an Alpha-linolenic Acid-rich Supplement on Ketogenesis and Plasma Fatty Acids
Healthy
Primary: Ketone Production — 217.71; 187.48 µmol/L
Phase 3 N=86 Role of Soy Supplementation in Prostate Cancer Development
Prostate Neoplasm
Primary: Effect of Soy Isoflavones on Serum Testosterone Levels. — 376; 405 ng/ml
N/A N=105 Protein Supplementation in Elderly With Sarcopenic Obesity Undergoing Caloric Restriction and Exercise
Sarcopenic Obesity · Aging
Primary: Percentage of Fat-free Mass — 49.6; 50.3; 50.5; 52.5 percentage of fat-free mass — p=0.013